Related Experiment Video
Updated: Aug 5, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Changing ideas on antiviral agents for respiratory infection
Abstract:
Since the early 1950s it has been shown that some nontoxic antiviral substances, given either orally or intransally, can inhibit the growth of respiratory viruses and their clinical effects. The next targets of research are the improvement of present methods of drug administration and the exploration of the possibility of giving drugs in combination. The most potent antiviral agents available should be used to establish whether drugs given when symptoms commence can have a significant effect, i.e., whether antiviral therapy is possible.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

